| Omicron variant evolution on vaccines and monoclonal antibodies M Sabbatucci, A Vitiello, S Clemente, A Zovi, M Boccellino, F Ferrara, ... Inflammopharmacology 31 (4), 1779-1788, 2023 | 27 | 2023 |
| Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected F Ferrara, A Zovi, M Masi, R Langella, U Trama, M Boccellino, A Vitiello Naunyn-schmiedeberg's Archives of Pharmacology 396 (7), 1583-1589, 2023 | 19 | 2023 |
| Recovery of suspended reimbursements of high-cost drugs subjected to monitoring registries and negotiated agreements (MEAs): a tool for governance and clinical appropriateness … M Capuozzo, V Celotto, A Zovi, R Langella, F Ferrara The European Journal of Health Economics 25 (1), 1-5, 2024 | 13 | 2024 |
| The impact of an automated dispensing system for supplying narcotics in a surgical unit: the experience of the National cancer Institute Foundation of Milan G Portelli, M Canobbio, R Bitonti, C Della Costanza, R Langella, V Ladisa Hospital Pharmacy 54 (5), 335-342, 2019 | 13 | 2019 |
| New drugs for type 2 diabetes mellitus: The challenge of the health care sustainability combined with a better patient care access F Ferrara, A Zovi, R Langella, F Cavallaro, E Nava, U Trama, A Vitiello International Journal of Healthcare Management 17 (3), 556-561, 2024 | 11 | 2024 |
| Liver injury and dietary supplements: Does hydroxycitric acid trigger hepatotoxicity? A Zovi, R Langella, A Nisic, A Vitiello, UM Musazzi Journal of Integrative Medicine 20 (5), 473-475, 2022 | 11 | 2022 |
| Sex affects immune response capacity against COVID‐19 infection A Zovi, F Ferrara, R Langella, F Cavallaro, A Vitiello Reviews in Medical Virology 33 (4), e2450, 2023 | 10 | 2023 |
| Pharmacological agents with antiviral activity against monkeypox infection A Zovi, F Ferrara, R Langella, A Vitiello International Journal of Molecular Sciences 23 (24), 15941, 2022 | 10 | 2022 |
| Atrial fibrillation therapy with new oral anticoagulants: a real world evidence study F Ferrara, U Trama, E Nava, M Capuozzo, A Zovi, F Valentino, R Langella International Journal of Healthcare Management, 1-4, 2023 | 8 | 2023 |
| Atopic dermatitis: treatment and innovations in immunotherapy F Ferrara, A Zovi, M Capuozzo, R Langella Inflammopharmacology 32 (3), 1777-1789, 2024 | 7 | 2024 |
| Healthcare systems and artificial intelligence: focus on challenges and the international regulatory framework A Romagnoli, F Ferrara, R Langella, A Zovi Pharmaceutical Research 41 (4), 721-730, 2024 | 7 | 2024 |
| Trend analysis of proton pump inhibitor consumption and expenditure: the real-world evidence F Ferrara, M Capuozzo, V Celotto, A Ottaiano, R Langella, A Zovi Indian Journal of Gastroenterology, 1-7, 2024 | 6 | 2024 |
| Therapeutic and Unconventional Strategies to Contrast Antimicrobial Resistance: A Literature Review. A Vitiello, M Sabbatucci, M Boccellino, A Ponzo, R Langella, A Zovi Discovery Medicine 35 (178), 750-756, 2023 | 6 | 2023 |
| Antibiotic consumption in primary care in Costa Rica and Italy: a retrospective cross-country analysis E Zavaleta, F Ferrara, A Zovi, JP Díaz-Madriz, A Fallas-Mora, ... Cureus 15 (7), 2023 | 6 | 2023 |
| Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) C Jommi, P Armeni, F Costa, C Alberti, F Bandello, R Bordonaro, ... Recenti Progressi in Medicina 112 (11), 749-756, 2021 | 5 | 2021 |
| The challenge of antimicrobial resistance (AMR): Current status and future prospects F Ferrara, T Castagna, B Pantolini, MC Campanardi, M Roperti, A Grotto, ... Naunyn-Schmiedeberg's Archives of Pharmacology, 1-13, 2024 | 4 | 2024 |
| Analysis of biosimilars consumption in an Italian Local Health Authority F Ferrara, M Capuozzo, R Langella, U Trama, E Nava, A Ottaiano, A Zovi Naunyn-Schmiedeberg's Archives of Pharmacology 397 (7), 5317-5323, 2024 | 4 | 2024 |
| Antibacterial agents and the fight against antibiotic resistance: A real-world evidence analysis of consumption and spending by an Italian healthcare company F Ferrara, M Capuozzo, R Pasquinucci, R Langella, U Trama, E Nava, ... Annales Pharmaceutiques Françaises 82 (3), 545-552, 2024 | 4 | 2024 |
| The direct correlation between Covid-19 and attention deficit/hyperactivity disorder (ADHD) F Ferrara, E Zavaleta, A Vitiello, JA Villalobos, A Zovi, R Langella, ... European Neuropsychopharmacology 73, 62, 2023 | 4 | 2023 |
| The Impact of Antimicrobial Resistance in cystic fibrosis A Vitiello, F Blasi, M Sabbatucci, A Zovi, F Miele, A Ponzo, R Langella, ... Journal of Clinical Medicine 13 (6), 1711, 2024 | 3 | 2024 |
